Gyre Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.

About GYRE

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). 

CEO
Ping Zhang
CEOPing Zhang
Employees
625
Employees625
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1997
Founded1997
Employees
625
Employees625

GYRE Key Statistics

Market cap
767.22M
Market cap767.22M
Price-Earnings ratio
352.00
Price-Earnings ratio352.00
Dividend yield
Dividend yield
Average volume
51.18K
Average volume51.18K
High today
$8.05
High today$8.05
Low today
$7.83
Low today$7.83
Open price
$8.02
Open price$8.02
Volume
24.50K
Volume24.50K
52 Week high
$11.78
52 Week high$11.78
52 Week low
$6.57
52 Week low$6.57

Stock Snapshot

The current Gyre Therapeutics(GYRE) stock price is $7.91, with a market capitalization of 767.22M. The stock trades at a price-to-earnings (P/E) ratio of 352.00.

As of 2026-05-05, Gyre Therapeutics(GYRE) stock has fluctuated between $7.83 and $8.05. The current price stands at $7.91, placing the stock +1.0% above today's low and -1.7% off the high.

Gyre Therapeutics(GYRE) shares are trading with a volume of 24.5K, against a daily average of 51.18K.

In the last year, Gyre Therapeutics(GYRE) shares hit a 52-week high of $11.78 and a 52-week low of $6.57.

In the last year, Gyre Therapeutics(GYRE) shares hit a 52-week high of $11.78 and a 52-week low of $6.57.

People also own

Based on the portfolios of people who own GYRE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.